Northern Trust Corp Enzo Biochem Inc Transaction History
Northern Trust Corp
- $658 Billion
- Q1 2025
A detailed history of Northern Trust Corp transactions in Enzo Biochem Inc stock. As of the latest transaction made, Northern Trust Corp holds 67,204 shares of ENZ stock, worth $36,962. This represents 0.0% of its overall portfolio holdings.
Number of Shares
67,204
Previous 67,204
-0.0%
Holding current value
$36,962
Previous $47,000
48.94%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding ENZ
# of Institutions
46Shares Held
16.4MCall Options Held
0Put Options Held
0-
Harbert Fund Advisors, Inc. Birmingham, AL5.18MShares$2.85 Million2.17% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.08MShares$1.15 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.86MShares$1.02 Million0.0% of portfolio
-
Potomac Capital Management, Inc.1.48MShares$814,9583.63% of portfolio
-
Viex Capital Advisors, LLC Sunny Isles Beach, FL1.33MShares$733,9639.62% of portfolio
About ENZO BIOCHEM INC
- Ticker ENZ
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 48,720,500
- Market Cap $26.8M
- Description
- Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...